Cargando…

First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal

BACKGROUND: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown. METHODS AND FINDINGS: We analyzed 261 M. tubercul...

Descripción completa

Detalles Bibliográficos
Autores principales: Malla, Bijaya, Stucki, David, Borrell, Sonia, Feldmann, Julia, Maharjan, Bhagwan, Shrestha, Bhawana, Fenner, Lukas, Gagneux, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530561/
https://www.ncbi.nlm.nih.gov/pubmed/23300635
http://dx.doi.org/10.1371/journal.pone.0052297
_version_ 1782254030963081216
author Malla, Bijaya
Stucki, David
Borrell, Sonia
Feldmann, Julia
Maharjan, Bhagwan
Shrestha, Bhawana
Fenner, Lukas
Gagneux, Sebastien
author_facet Malla, Bijaya
Stucki, David
Borrell, Sonia
Feldmann, Julia
Maharjan, Bhagwan
Shrestha, Bhawana
Fenner, Lukas
Gagneux, Sebastien
author_sort Malla, Bijaya
collection PubMed
description BACKGROUND: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown. METHODS AND FINDINGS: We analyzed 261 M. tuberculosis isolates recovered from pulmonary TB patients recruited between August 2009 and August 2010 in Nepal. M. tuberculosis lineages were determined by single nucleotide polymorphisms (SNP) typing and spoligotyping. Drug resistance was determined by sequencing the hot spot regions of the relevant target genes. Overall, 164 (62.8%) TB patients were new, and 97 (37.2%) were previously treated. Any drug resistance was detected in 50 (19.2%) isolates, and 16 (6.1%) were multidrug-resistant. The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). Based on spoligotyping, we found 45 different spoligotyping patterns that were previously described. The Beijing (83 isolates, 31.8%) and CAS spoligotype (52, 19.9%) were the dominant spoligotypes. A total of 36 (13.8%) isolates could not be assigned to any known spoligotyping pattern. Lineage 2 was associated with female sex (adjusted odds ratio [aOR] 2.58, 95% confidence interval [95% CI] 1.42–4.67, p = 0.002), and any drug resistance (aOR 2.79; 95% CI 1.43–5.45; p = 0.002). We found no evidence for an association of Lineage 2 with age or BCG vaccination status. CONCLUSIONS: We found a large genetic diversity of M. tuberculosis in Nepal with representation of all four major lineages. Lineages 3 and 2 were dominating. Lineage 2 was associated with clinical characteristics. This study fills an important gap on the map of the M. tuberculosis genetic diversity in the Asian region.
format Online
Article
Text
id pubmed-3530561
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35305612013-01-08 First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal Malla, Bijaya Stucki, David Borrell, Sonia Feldmann, Julia Maharjan, Bhagwan Shrestha, Bhawana Fenner, Lukas Gagneux, Sebastien PLoS One Research Article BACKGROUND: Tuberculosis (TB) is a major public health problem in Nepal. Strain variation in Mycobacterium tuberculosis may influence the outcome of TB infection and disease. To date, the phylogenetic diversity of M. tuberculosis in Nepal is unknown. METHODS AND FINDINGS: We analyzed 261 M. tuberculosis isolates recovered from pulmonary TB patients recruited between August 2009 and August 2010 in Nepal. M. tuberculosis lineages were determined by single nucleotide polymorphisms (SNP) typing and spoligotyping. Drug resistance was determined by sequencing the hot spot regions of the relevant target genes. Overall, 164 (62.8%) TB patients were new, and 97 (37.2%) were previously treated. Any drug resistance was detected in 50 (19.2%) isolates, and 16 (6.1%) were multidrug-resistant. The most frequent M. tuberculosis lineage was Lineage 3 (CAS/Delhi) with 106 isolates (40.6%), followed by Lineage 2 (East-Asian lineage, includes Beijing genotype) with 84 isolates (32.2%), Lineage 4 (Euro-American lineage) with 41 (15.7%) isolates, and Lineage 1 (Indo-Oceanic lineage) with 30 isolates (11.5%). Based on spoligotyping, we found 45 different spoligotyping patterns that were previously described. The Beijing (83 isolates, 31.8%) and CAS spoligotype (52, 19.9%) were the dominant spoligotypes. A total of 36 (13.8%) isolates could not be assigned to any known spoligotyping pattern. Lineage 2 was associated with female sex (adjusted odds ratio [aOR] 2.58, 95% confidence interval [95% CI] 1.42–4.67, p = 0.002), and any drug resistance (aOR 2.79; 95% CI 1.43–5.45; p = 0.002). We found no evidence for an association of Lineage 2 with age or BCG vaccination status. CONCLUSIONS: We found a large genetic diversity of M. tuberculosis in Nepal with representation of all four major lineages. Lineages 3 and 2 were dominating. Lineage 2 was associated with clinical characteristics. This study fills an important gap on the map of the M. tuberculosis genetic diversity in the Asian region. Public Library of Science 2012-12-26 /pmc/articles/PMC3530561/ /pubmed/23300635 http://dx.doi.org/10.1371/journal.pone.0052297 Text en © 2012 Malla et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Malla, Bijaya
Stucki, David
Borrell, Sonia
Feldmann, Julia
Maharjan, Bhagwan
Shrestha, Bhawana
Fenner, Lukas
Gagneux, Sebastien
First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title_full First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title_fullStr First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title_full_unstemmed First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title_short First Insights into the Phylogenetic Diversity of Mycobacterium tuberculosis in Nepal
title_sort first insights into the phylogenetic diversity of mycobacterium tuberculosis in nepal
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530561/
https://www.ncbi.nlm.nih.gov/pubmed/23300635
http://dx.doi.org/10.1371/journal.pone.0052297
work_keys_str_mv AT mallabijaya firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT stuckidavid firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT borrellsonia firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT feldmannjulia firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT maharjanbhagwan firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT shresthabhawana firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT fennerlukas firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal
AT gagneuxsebastien firstinsightsintothephylogeneticdiversityofmycobacteriumtuberculosisinnepal